The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery/indefinite quantity contract under the Safe Healthcare, Epidemiology, and Prevention Research Development Program to Duke University Office of Research Administration Division. With a potential value of $99 million and a period of performance through September 2026, this contract vehicle aims to procure epidemiological, behavioral and social science research and services across several domains including...
Duke University Office of Research Administration Division was awarded a multiple-award indefinite delivery/indefinite quantity (IDIQ) contract from the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) program. The contract has a potential value of $200,000,000 and a period of performance through September 29, 2021. As the prime contractor, Duke University is providing clinical research and...
This indefinite delivery contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency of the U.S. federal government, to Duke University, a private research university. The contract, valued at up to $149,000,000, supports the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network (PTN) program, which is responsible for designing, conducting, and overseeing clinical, scientific, and technical aspects of pediatric drug...
This indefinite delivery contract, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Duke University, aims to support the Best Pharmaceuticals for Children Act - Pediatric Trials Network (BPCA-PTN) program. The $96,000,000 contract has an ultimate completion date of June 3, 2026 and does not utilize any set-aside designations. Under this IDV, Duke University's Office of Research Administration Division is the prime contractor and will...
The University of North Carolina at Chapel Hill (UNC), through its Office of Sponsored Research, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services. The contract, valued at $22,004,772, has a period of performance through November 14, 2029. Under this IDC, UNC is serving as the coordinating center for the Atherosclerosis Risk in Communities (ARIC) Study, a...
This single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the Department of Health and Human Services, to the University of North Carolina at Chapel Hill (UNC-CH) to operate the Coordinating Center for the Hispanic Community Health Study - Study of Latinos (HCHS-SOL). The $35 million IDIQ contract has an ultimate completion date of November 29, 2033. Under this contract, UNC-CH will provide core study...
This federal Indefinite Delivery Contract (IDC) was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH), to the University of North Carolina at Chapel Hill (UNC-CH) to support the Atherosclerosis Risk in Communities (ARIC) study. The $5,998,555 single-award IDC has a period of performance through November 2022 and provides research services and operational support for the ARIC study's...
The Department of Health and Human Services National Heart Lung and Blood Institute (NHLBI) awarded an Indefinite Delivery Contract (IDC) to Wake Forest University Health Sciences, a private non-profit academic medical center, to serve as the Atherosclerosis Risk in Communities (ARIC) Study Field Center. The $7,955,041 single-award IDC has a period of performance through November 14, 2029. Under this contract, Wake Forest University Health Sciences will provide services related to the ARIC...
The federal contract IDV award HHSN271200800009C was a single award indefinite delivery contract issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The $2,162,027.85 contract, awarded to Duke University's Office of Research Administration, provided funding for an MTA study related to the National Institute of Mental Health (NIMH). This IDV did not have any set-aside designations. The period of performance extended from the...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Duke University's Office of Research Administration Division to support Phase 0 through Phase II clinical trials of investigational products against infectious diseases. The IDIQ contract, valued at up to $346,610,277, has a performance period from January 14, 2022 to January 13, 2032. Under this IDIQ, Duke...